Adverse Events

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

Physician’s Briefing

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

17 Jun 2026

2 min read

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

Physician’s Briefing

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

15 Jun 2026

1 min read

ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D

Physician’s Briefing

ERA: Dihydropyridine Calcium-Channel-Blockers Tied to Higher Risk for Kidney Disease Progression in T2D

08 Jun 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com